Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03395990 · ClinicalTrials.gov registry record · NA

Analgesic Value of Adductor Canal vs Femoral Block After Total Knee Arthroplasty

A NA study of Osteo Arthritis Knee, sponsored by Duke University.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT03395990 is a NA study of Osteo Arthritis Knee that has completed, run by Duke University. The registered enrollment target is 16 participants, below the 138-participant average among 22 other Osteo Arthritis Knee trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03395990, a NA study of Osteo Arthritis Knee, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

An observational study of the effect of femoral nerve block in addition to an adductor canal block for pain following total knee arthroplasty.

Conditions Studied

Interventions

  • PROCEDURE Active comparator: chloroprocaine
  • PROCEDURE Sham comparator: saline

Study Locations (1)

North Carolina

  • Duke University Hospital - Durham

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2016-03-27
Est. Completion 2016-10-19
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03395990

The ClinicalTrials.gov registry entry for NCT03395990 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 138-participant average among 22 other Osteo Arthritis Knee trials with a reported enrollment target (88% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteo Arthritis Knee appearing as the primary indexed condition, and to 2 interventions - of which Active comparator: chloroprocaine is the first listed.

NCT03395990 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03395990 about?

NCT03395990 is a clinical study titled "Analgesic Value of Adductor Canal vs Femoral Block After Total Knee Arthroplasty". An observational study of the effect of femoral nerve block in addition to an adductor canal block for pain following total knee arthroplasty.

What is the current status of trial NCT03395990?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-03-27. Estimated completion is 2016-10-19.

What conditions does trial NCT03395990 study?

This clinical trial studies the following conditions: Osteo Arthritis Knee.

What interventions are being tested in trial NCT03395990?

The interventions under investigation include: Active comparator: chloroprocaine (PROCEDURE), Sham comparator: saline (PROCEDURE).

Who is sponsoring clinical trial NCT03395990?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03395990 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteo Arthritis Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.